KLWA
Kelly Lawrence W & Associates Portfolio holdings
AUM
$382M
This Quarter Return
+0.52%
1 Year Return
+13.86%
3 Year Return
+61.56%
5 Year Return
+124.1%
10 Year Return
+368.26%
AUM
$528M
AUM Growth
+$528M
(-2.9%)
Cap. Flow
-$7.87M
Cap. Flow
% of AUM
-1.49%
Top 10 Holdings %
Top 10 Hldgs %
37.37%
Holding
163
New
5
Increased
15
Reduced
49
Closed
27
Top Buys
| 1 |
Danaher
DHR
|
$15M |
| 2 |
Fiserv
FI
|
$14.8M |
| 3 |
CommScope
COMM
|
$14.6M |
| 4 |
Advanced Micro Devices
AMD
|
$8.73M |
| 5 |
Halliburton
HAL
|
$6.51M |
Top Sells
| 1 |
OA
Orbital ATK, Inc.
OA
|
$15.3M |
| 2 |
PE
PARSLEY ENERGY INC
PE
|
$13.2M |
| 3 |
Check Point Software Technologies
CHKP
|
$12.5M |
| 4 |
Goldman Sachs
GS
|
$8.44M |
| 5 |
Enovis
ENOV
|
$7.04M |
Sector Composition
| 1 | Technology | 23.89% |
| 2 | Healthcare | 19.06% |
| 3 | Financials | 18.46% |
| 4 | Consumer Discretionary | 9.83% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Regeneron Pharmaceuticals
REGN
$61.5B
| $8.58M | 1.63% |
24,925
-340
| -1% | -$117K |
|
27
Chevron
CVX
$324B
| $7.86M | 1.49% |
68,896
-1,000
| -1% | -$114K |
|
28
Merck
MRK
$210B
| $7.41M | 1.4% |
136,060
+350
| +0.3% | +$19.1K |
|
29
JPMorgan Chase
JPM
$829B
| $7.28M | 1.38% |
66,210
+5,600
| +9% | +$616K |
|
30
Edwards Lifesciences
EW
$47.8B
| $6.85M | 1.3% |
49,100
-3,200
| -6% | -$447K |
|
31
Cisco
CSCO
$274B
| $6.77M | 1.28% |
157,926
-3,325
| -2% | -$143K |
|
32
Salesforce
CRM
$245B
| $6.57M | 1.24% |
56,475
+15,475
| +38% | +$1.8M |
|
|
33
Halliburton
HAL
$19.4B
| $6.51M | 1.23% |
+138,750
| New | +$6.51M |
|
34
Alphabet (Google) Class C
GOOG
$2.58T
| $6.49M | 1.23% |
6,287
-250
| -4% | -$258K |
|
35
Applied Materials
AMAT
$128B
| $5.41M | 1.02% |
97,305
-20,800
| -18% | -$1.16M |
|
36
DuPont de Nemours
DD
$32.2B
| $5.26M | 1% |
82,575
+250
| +0.3% | +$15.9K |
|
37
Aflac
AFL
$57.2B
| $3.21M | 0.61% |
73,248
-27,026
| -27% | -$1.18M |
|
38
Procter & Gamble
PG
$368B
| $3.13M | 0.59% |
39,455
+300
| +0.8% | +$23.8K |
|
39
AbbVie
ABBV
$372B
| $2.38M | 0.45% |
25,145
-1,200
| -5% | -$114K |
|
40
Gilead Sciences
GILD
$140B
| $2.23M | 0.42% |
29,605
| – | – |
|
41
Vertex Pharmaceuticals
VRTX
$100B
| $2.18M | 0.41% |
13,347
-6,955
| -34% | -$1.13M |
|
42
3M
MMM
$82.8B
| $2.15M | 0.41% |
9,792
-1,000
| -9% | -$220K |
|
43
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
$4.82B
| $1.9M | 0.36% |
1,475
| – | – |
|
|
RDS.A
44
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.76M | 0.33% |
27,574
| – | – |
|
45
Exxon Mobil
XOM
$487B
| $1.66M | 0.31% |
22,268
+3,000
| +16% | +$224K |
|
|
CYS.PRB
46
DELISTED
CYS Investments, Inc.
CYS.PRB
| $1.49M | 0.28% |
63,050
| – | – |
|
47
Verizon
VZ
$186B
| $1.47M | 0.28% |
30,675
| – | – |
|
48
GE Aerospace
GE
$292B
| $1.03M | 0.19% |
76,298
| – | – |
|
49
Albemarle
ALB
$9.99B
| $952K | 0.18% |
10,267
-2,650
| -21% | -$246K |
|
50
Amgen
AMGN
$155B
| $931K | 0.18% |
5,463
-30
| -0.5% | -$5.11K |
|